abstract |
Treatment of compounds that inhibit Lp-PLA2 activity, processes for their production, compositions containing them, and diseases associated with the activity of Lp-PLA2, such as atherosclerosis, Alzheimer's disease, and / or diabetic macular edema Disclose their use in. |